Ibuprofen racemate or enantiomers [Design Issues]

posted by janmacek – Czech Republic, 2011-08-02 17:49 (5437 d 13:53 ago) – Posting: # 7251
Views: 4,493

Dear all,

have you any recent experience with bioequivalence study with ibuprofen (administration of a racemate)? According to the recent EMA Bioequivalence guideline it seems me that enantiomers of this drug should be measured, because all three prerequisites for such design are met. However, I have seen many recent studies where only an achiral method was used. Also the FDA recommends to measure "ibuprofen in plasma", i.e. racemate.

With best regards,

Jan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
127 visitors (0 registered, 127 guests [including 29 identified bots]).
Forum time: 07:43 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5